USD 4.2
(-0.94%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 501.06 Million USD | 2.77% |
2023 | 487.56 Million USD | 35.46% |
2022 | 359.92 Million USD | 18.28% |
2021 | 304.29 Million USD | 28.5% |
2020 | 236.81 Million USD | 31.29% |
2019 | 180.37 Million USD | 10.32% |
2018 | 163.5 Million USD | 2.11% |
2017 | 160.13 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 487.07 Million USD | -0.1% |
2024 Q3 | 504.1 Million USD | 4.59% |
2024 Q4 | 501.06 Million USD | -0.6% |
2024 Q2 | 482 Million USD | -1.04% |
2023 Q3 | 512.53 Million USD | -9.48% |
2023 Q2 | 566.23 Million USD | 20.36% |
2023 FY | 487.56 Million USD | 35.46% |
2023 Q1 | 470.45 Million USD | 30.71% |
2023 Q4 | 487.56 Million USD | -4.87% |
2022 Q4 | 359.92 Million USD | -6.88% |
2022 Q3 | 386.51 Million USD | 7.9% |
2022 Q2 | 358.22 Million USD | 1.06% |
2022 Q1 | 354.45 Million USD | 16.48% |
2022 FY | 359.92 Million USD | 18.28% |
2021 FY | 304.29 Million USD | 28.5% |
2021 Q4 | 304.29 Million USD | 7.59% |
2021 Q3 | 282.82 Million USD | 5.58% |
2021 Q2 | 267.88 Million USD | 7.87% |
2021 Q1 | 248.33 Million USD | 4.87% |
2020 Q4 | 236.81 Million USD | 4.43% |
2020 Q3 | 226.76 Million USD | 13.09% |
2020 Q2 | 200.51 Million USD | 4.67% |
2020 Q1 | 191.55 Million USD | 6.2% |
2020 FY | 236.81 Million USD | 31.29% |
2019 Q3 | 182.36 Million USD | 197579.82% |
2019 Q4 | 180.37 Million USD | -1.09% |
2019 Q2 | 92.25 Thousand USD | 32.56% |
2019 Q1 | 69.59 Thousand USD | -30.8% |
2019 FY | 180.37 Million USD | 10.32% |
2018 Q4 | 100.57 Thousand USD | 62.21% |
2018 FY | 163.5 Million USD | 2.11% |
2018 Q3 | 62 Thousand USD | 12.2% |
2018 Q2 | 55.26 Thousand USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 FY | 160.13 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Muliang Viagoo Technology, Inc. | 9.29 Million USD | -5288.895% |
N2OFF, Inc. | 785.65 Thousand USD | -63676.755% |
Arcadia Biosciences, Inc. | 7 Million USD | -7056.012% |
Yield10 Bioscience, Inc. | 6.39 Million USD | -7741.377% |